Cellular aging and cancer

Peter J Hornsby

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aging is manifest in a variety of changes over time, including changes at the cellular level. Cellular aging acts primarily as a tumor suppressor mechanism, but also may enhance cancer development under certain circumstances. One important process of cellular aging is oncogene-induced senescence, which acts as a significant anti-cancer mechanism. Cellular senescence resulting from damage caused by activated oncogenes prevents the growth of potentially neoplastic cells. Moreover, cells that have entered senescence appear to be targets for elimination by the innate immune system. In another aspect of cellular aging, the absence of telomerase activity in normal tissues results in such cells lacking a telomere maintenance mechanism. One consequence is that in aging there is an increase in cells with shortened telomeres. In the presence of active oncogenes that cause expansion of a neoplastic clone, shortening of telomeres, leading to telomere dysfunction, prevents the indefinite expansion of the clone, because the cells enter crisis. Crisis results from chromosome fusions and other defects caused by dysfunctional telomeres and is a terminal state of the neoplastic clone. In this way the absence of telomerase in human cells, while one cause of cellular aging, also acts as an anti-cancer mechanism.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalCritical Reviews in Oncology/Hematology
Volume79
Issue number2
DOIs
StatePublished - Aug 2011

Fingerprint

Cell Aging
Telomere
Oncogenes
Telomere Shortening
Clone Cells
Telomerase
Neoplasms
Immune System
Chromosomes
Maintenance
Growth

Keywords

  • Aging
  • Cancer development
  • Crisis
  • Experimental tumorigenesis
  • Inflammation
  • Innate immunity
  • Senescence
  • Telomeres
  • Tumor suppression

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology

Cite this

Cellular aging and cancer. / Hornsby, Peter J.

In: Critical Reviews in Oncology/Hematology, Vol. 79, No. 2, 08.2011, p. 189-195.

Research output: Contribution to journalArticle

Hornsby, Peter J. / Cellular aging and cancer. In: Critical Reviews in Oncology/Hematology. 2011 ; Vol. 79, No. 2. pp. 189-195.
@article{7f5e8c8d3ed541439994a28781cd742e,
title = "Cellular aging and cancer",
abstract = "Aging is manifest in a variety of changes over time, including changes at the cellular level. Cellular aging acts primarily as a tumor suppressor mechanism, but also may enhance cancer development under certain circumstances. One important process of cellular aging is oncogene-induced senescence, which acts as a significant anti-cancer mechanism. Cellular senescence resulting from damage caused by activated oncogenes prevents the growth of potentially neoplastic cells. Moreover, cells that have entered senescence appear to be targets for elimination by the innate immune system. In another aspect of cellular aging, the absence of telomerase activity in normal tissues results in such cells lacking a telomere maintenance mechanism. One consequence is that in aging there is an increase in cells with shortened telomeres. In the presence of active oncogenes that cause expansion of a neoplastic clone, shortening of telomeres, leading to telomere dysfunction, prevents the indefinite expansion of the clone, because the cells enter crisis. Crisis results from chromosome fusions and other defects caused by dysfunctional telomeres and is a terminal state of the neoplastic clone. In this way the absence of telomerase in human cells, while one cause of cellular aging, also acts as an anti-cancer mechanism.",
keywords = "Aging, Cancer development, Crisis, Experimental tumorigenesis, Inflammation, Innate immunity, Senescence, Telomeres, Tumor suppression",
author = "Hornsby, {Peter J}",
year = "2011",
month = "8",
doi = "10.1016/j.critrevonc.2010.07.011",
language = "English (US)",
volume = "79",
pages = "189--195",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Cellular aging and cancer

AU - Hornsby, Peter J

PY - 2011/8

Y1 - 2011/8

N2 - Aging is manifest in a variety of changes over time, including changes at the cellular level. Cellular aging acts primarily as a tumor suppressor mechanism, but also may enhance cancer development under certain circumstances. One important process of cellular aging is oncogene-induced senescence, which acts as a significant anti-cancer mechanism. Cellular senescence resulting from damage caused by activated oncogenes prevents the growth of potentially neoplastic cells. Moreover, cells that have entered senescence appear to be targets for elimination by the innate immune system. In another aspect of cellular aging, the absence of telomerase activity in normal tissues results in such cells lacking a telomere maintenance mechanism. One consequence is that in aging there is an increase in cells with shortened telomeres. In the presence of active oncogenes that cause expansion of a neoplastic clone, shortening of telomeres, leading to telomere dysfunction, prevents the indefinite expansion of the clone, because the cells enter crisis. Crisis results from chromosome fusions and other defects caused by dysfunctional telomeres and is a terminal state of the neoplastic clone. In this way the absence of telomerase in human cells, while one cause of cellular aging, also acts as an anti-cancer mechanism.

AB - Aging is manifest in a variety of changes over time, including changes at the cellular level. Cellular aging acts primarily as a tumor suppressor mechanism, but also may enhance cancer development under certain circumstances. One important process of cellular aging is oncogene-induced senescence, which acts as a significant anti-cancer mechanism. Cellular senescence resulting from damage caused by activated oncogenes prevents the growth of potentially neoplastic cells. Moreover, cells that have entered senescence appear to be targets for elimination by the innate immune system. In another aspect of cellular aging, the absence of telomerase activity in normal tissues results in such cells lacking a telomere maintenance mechanism. One consequence is that in aging there is an increase in cells with shortened telomeres. In the presence of active oncogenes that cause expansion of a neoplastic clone, shortening of telomeres, leading to telomere dysfunction, prevents the indefinite expansion of the clone, because the cells enter crisis. Crisis results from chromosome fusions and other defects caused by dysfunctional telomeres and is a terminal state of the neoplastic clone. In this way the absence of telomerase in human cells, while one cause of cellular aging, also acts as an anti-cancer mechanism.

KW - Aging

KW - Cancer development

KW - Crisis

KW - Experimental tumorigenesis

KW - Inflammation

KW - Innate immunity

KW - Senescence

KW - Telomeres

KW - Tumor suppression

UR - http://www.scopus.com/inward/record.url?scp=79960187460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960187460&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2010.07.011

DO - 10.1016/j.critrevonc.2010.07.011

M3 - Article

C2 - 20705476

AN - SCOPUS:79960187460

VL - 79

SP - 189

EP - 195

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -